冠状病毒疾病2019 (COVID-19) 儿童移植接种者的疫苗接种覆盖率和有效性
Elizabeth Cohen1, Sarah Hinderstein2, Eve Carciofi3
1Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, USA.
概括
儿科移植患者的COVID-19疫苗接种率较低,只有54.1%完成了3剂. 疫苗接种减少了严重感染,对SARS-CoV-2的有效率为52.6%.
科学领域:
- 免疫学 免疫学 免疫学
- 儿科医学 儿科医学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 关于儿童固体器官和骨髓移植接受者的COVID-19疫苗接种和有效性的数据有限.
- 这些免疫功能低下的患者可能对接种疫苗的反应发生了改变.
研究的目的:
- 评估儿童心脏,肝脏,脏和骨髓移植接受者的真实世界COVID-19疫苗接种率和结果.
- 为了确定COVID-19疫苗在这种脆弱人群中对SARS-CoV-2感染的有效性.
主要方法:
- 从2020年3月到2024年1月进行了一项观察性队列研究.
- 对133名儿科移植患者收集了COVID-19疫苗接种状态,SARS-CoV-2感染和临床结果的数据.
主要成果:
- 只有54.1%的患者完成了至少3剂COVID-19疫苗接种.
- 在55.6%的患者中发生了SARS-CoV-2感染,在接种疫苗的人中住院病例较少,没有严重病例.
- 针对SARS-CoV-2感染的调整后疫苗有效率估计为52.6%.
结论:
- 在儿科移植接受者中,COVID-19疫苗接种率和初级系列完成率仍然低于最佳水平.
- 疫苗接种似乎可以减少这种人群中严重的COVID-19结果.
- 需要进一步的研究来改善疫苗的接受度和了解疫苗有效性动态.
相关概念视频
Kidney Transplant I: Introduction
339
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
339
Pharmacokinetics in Pediatric Patients: Drug Distribution
251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
Bone Marrow Sampling and Transplants
876
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
876
Pharmacokinetics in Pediatric Patients: Drug Excretion
209
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
209
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
241
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
241
Pharmacokinetics in Pediatric Patients: Drug Metabolism
191
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
191


